Mitoxantrone is a dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone that is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8. Among its listed roles, it functions as a antineoplastic agent and an analgesic. An anthracenedione-derived antineoplastic agent. Mitoxantrone is a Topoisomerase Inhibitor. The mechanism of action of mitoxantrone is as a Topoisomerase Inhibitor. It is grouped under the following drug class(es): Anthracyclines, Cytotoxics and Topoisomerase inhibitors. Its therapeutic use is listed as anti-cancer agents and multiple sclerosis agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Misostol, Mitozantrone and Novantrone. Its PubChem CID is 4212.
Mitoxantrone
| CAS No | 65271-80-9 |
|---|---|
| Molecular Formula | C22H28N4O6 |
| Molecular Weight | 444.50 g/mol |
| Synonyms | 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Mitoxantrone is a dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone that is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8. Among its listed roles, it functions as a antineoplastic agent and an analgesic.
The listed CAS number is 65271-80-9.
The listed molecular formula is C22H28N4O6.
The listed molecular weight is 444.50 g/mol.
1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione.
The source lists Misostol, Mitozantrone and Novantrone.